Periodic Reporting for period 2 - ONCORNET2.0 (ONCOgenic Receptor Network of Excellence and Training 2.0)
Período documentado: 2022-02-01 hasta 2024-01-31
The key objective of this MSCA-ITN-ONCORNET2.0 initiative is to train the next generation of 15 ESRs by offering an extensive multidisciplinary training programme to ensure that they can operate in today’s drug discovery programmes. This includes both research (e.g. drug discovery, proteomics, imaging, modelling) and transferable (e.g. entrepreneurship, writing, media training) skill sets – that is rarely offered at PhD level.
As of February 2021, biweekly online meetings with ESR presentations and Technology forums alternate; this way we aim to facilitate and strengthen the interactions amongst the ESRs and different research groups within Academia and SMEs.